Chronic HCV Hepatitis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in G1b Treatment-Naïve, HCV-Infected Patients (NCT03496233) | Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo | 2018-09-19 |
Track Chronic HCV Hepatitis automatically
Every clearance here is in the API, with alerts when new ones post.